XGN logo

Exagen (XGN) Cash From Investing

Annual CFI

-$804.00 K
+$3.51 M+81.38%

December 31, 2023

Summary

Performance

1-Year Change

+81.38%

3-Year Change

-76.7%

5-Year Change

-304.02%

15-Year Change

-57.65%

XGN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.47%
XGN annual cash flow from investing activities is higher than 46.47% of companies in Healthcare sector

High & Low

All-time High

$549.00 K
XGN annual cash flow from investing activities is currently -246.45% below its historical high of $549.00 thousand

3-Year Low

-$4.32 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
XGN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 18, 2025
XGN next annual earnings announcement is scheduled for Mar 18, 2025

OtherXGNcash flowmetrics:

Annual CFF

-$10.63 M
XGN annual cash flow from financing activities is -$10.63 million

Annual CFO

-$14.46 M
XGN annual cash flow from operations is -$14.46 million

Annual FCF

-$15.29 M
XGN annual free cash flow is -$15.29 million

Annual CAPEX

$828.00 K
XGN annual capital expenditures is $828.00 thousand

Quarterly CFI

-$147.00 K
-$11.00 K-8.09%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-7250%

3-Year Change

+69.05%

5-Year Change

+30.99%

XGN Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

41.79%
XGN quarterly cash flow from investing activities is higher than 41.79% of companies in Healthcare sector

High & Low

All-time High

$288.00 K
XGN quarterly cash flow from investing activities is currently -151.04% below its historical high of $288.00 thousand

3-Year Low

-$1.95 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
XGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
XGN next earnings announcement is scheduled for Mar 18, 2025

OtherXGNcash flowmetrics:

Quarterly CFF

-$121.00 K
XGN quarterly cash flow from financing activities is -$121.00 thousand

Quarterly CFO

-$2.18 M
XGN quarterly cash flow from operations is -$2.18 million

Quarterly FCF

-$2.32 M
XGN quarterly free cash flow is -$2.32 million

Quarterly CAPEX

$147.00 K
XGN quarterly capital expenditures is $147.00 thousand

TTM CFI

-$453.00 K
-$145.00 K-47.08%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+59.77%

3-Year Change

+66.72%

5-Year Change

+4.83%

XGN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

49.54%
XGN TTM cash flow from investing activities is higher than 49.54% of companies in Healthcare sector

High & Low

All-time High

$176.00 K
XGN TTM cash flow from investing activities is currently -357.39% below its historical high of $176.00 thousand

3-Year Low

-$4.98 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
XGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
XGN next earnings announcement is scheduled for Mar 18, 2025

OtherXGNcash flowmetrics:

TTM CFF

-$667.00 K
XGN TTM cash flow from financing activities is -$667.00 thousand

TTM CFO

-$5.29 M
XGN TTM cash flow from operations is -$5.29 million

TTM FCF

-$5.77 M
XGN TTM free cash flow is -$5.77 million

TTM CAPEX

$475.00 K
XGN TTM capital expenditures is $475.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

XGN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+81.4%-7250.0%+59.8%
3 y3 years-76.7%+69.0%+66.7%
5 y5 years-304.0%+31.0%+4.8%

XGN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+81.4%-7250.0%+92.5%-47.1%+90.9%
5 y5-year-680.6%+81.4%-7250.0%+92.5%-357.4%+90.9%
alltimeall time-246.4%+81.4%-151.0%+92.5%-357.4%+90.9%

Exagen Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$147.00 K(+8.1%)
-$453.00 K(+47.1%)
Jun 2024
-
-$136.00 K(+58.1%)
-$308.00 K(-37.7%)
Mar 2024
-
-$86.00 K(+2.4%)
-$494.00 K(-38.6%)
Dec 2023
-$804.00 K(-81.4%)
-$84.00 K(+4100.0%)
-$804.00 K(-28.6%)
Sep 2023
-
-$2000.00(-99.4%)
-$1.13 M(-43.8%)
Jun 2023
-
-$322.00 K(-18.7%)
-$2.00 M(-44.8%)
Mar 2023
-
-$396.00 K(-2.5%)
-$3.63 M(-16.0%)
Dec 2022
-$4.32 M(+78.4%)
-$406.00 K(-53.8%)
-$4.32 M(-13.2%)
Sep 2022
-
-$879.00 K(-54.8%)
-$4.98 M(+8.8%)
Jun 2022
-
-$1.95 M(+79.0%)
-$4.57 M(+36.9%)
Mar 2022
-
-$1.09 M(+2.2%)
-$3.34 M(+38.0%)
Dec 2021
-$2.42 M(+431.9%)
-$1.06 M(+124.0%)
-$2.42 M(+77.8%)
Sep 2021
-
-$475.00 K(-33.5%)
-$1.36 M(+23.8%)
Jun 2021
-
-$714.00 K(+327.5%)
-$1.10 M(+104.3%)
Mar 2021
-
-$167.00 K(+3240.0%)
-$538.00 K(+18.2%)
Dec 2020
-$455.00 K
-$5000.00(-97.7%)
-$455.00 K(-4.4%)
Sep 2020
-
-$213.00 K(+39.2%)
-$476.00 K(+79.6%)
DateAnnualQuarterlyTTM
Jun 2020
-
-$153.00 K(+82.1%)
-$265.00 K(-250.6%)
Mar 2020
-
-$84.00 K(+223.1%)
$176.00 K(-270.9%)
Dec 2019
-$103.00 K(-48.2%)
-$26.00 K(+1200.0%)
-$103.00 K(+33.8%)
Sep 2019
-
-$2000.00(-100.7%)
-$77.00 K(+2.7%)
Jun 2019
-
$288.00 K(-179.3%)
-$75.00 K(-79.3%)
Mar 2019
-
-$363.00 K(+128.3%)
-$363.00 K(-54.6%)
Dec 2018
-$199.00 K(-61.0%)
-
-
Dec 2017
-$510.00 K(-36.3%)
-
-
Dec 2015
-$800.00 K(+23.3%)
-$159.00 K(-34.8%)
-$800.00 K(+17.0%)
Sep 2015
-
-$244.00 K(-37.3%)
-$684.00 K(+10.1%)
Jun 2015
-
-$389.00 K(+4762.5%)
-$621.00 K(+1.5%)
Mar 2015
-
-$8000.00(-81.4%)
-$612.00 K(-5.7%)
Dec 2014
-$649.00 K(-218.2%)
-$43.00 K(-76.2%)
-$649.00 K(+7.1%)
Sep 2014
-
-$181.00 K(-52.4%)
-$606.00 K(+42.6%)
Jun 2014
-
-$380.00 K(+744.4%)
-$425.00 K(+844.4%)
Mar 2014
-
-$45.00 K
-$45.00 K
Dec 2013
$549.00 K(-148.5%)
-
-
Dec 2012
-$1.13 M
-
-

FAQ

  • What is Exagen annual cash flow from investing activities?
  • What is the all time high annual CFI for Exagen?
  • What is Exagen annual CFI year-on-year change?
  • What is Exagen quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Exagen?
  • What is Exagen quarterly CFI year-on-year change?
  • What is Exagen TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Exagen?
  • What is Exagen TTM CFI year-on-year change?

What is Exagen annual cash flow from investing activities?

The current annual CFI of XGN is -$804.00 K

What is the all time high annual CFI for Exagen?

Exagen all-time high annual cash flow from investing activities is $549.00 K

What is Exagen annual CFI year-on-year change?

Over the past year, XGN annual cash flow from investing activities has changed by +$3.51 M (+81.38%)

What is Exagen quarterly cash flow from investing activities?

The current quarterly CFI of XGN is -$147.00 K

What is the all time high quarterly CFI for Exagen?

Exagen all-time high quarterly cash flow from investing activities is $288.00 K

What is Exagen quarterly CFI year-on-year change?

Over the past year, XGN quarterly cash flow from investing activities has changed by -$145.00 K (-7250.00%)

What is Exagen TTM cash flow from investing activities?

The current TTM CFI of XGN is -$453.00 K

What is the all time high TTM CFI for Exagen?

Exagen all-time high TTM cash flow from investing activities is $176.00 K

What is Exagen TTM CFI year-on-year change?

Over the past year, XGN TTM cash flow from investing activities has changed by +$673.00 K (+59.77%)